Literature DB >> 3455373

Struma ovarii: a case report.

J H Lazarus1, A R Richards, M J MacPherson, J S Dinnen, E D Williams, G M Owen, J S Wade.   

Abstract

A patient with struma ovarii and hyperthyroidism is described. She was treated for Graves' hyperthyroidism at age 22 and received thyroxine for post-operative hypothyroidism. Twenty years later she became thyrotoxic and was treated with antithyroid drugs and radioiodine. Diagnosis of struma ovarii was made by radioiodine profile scanning and an ovarian tumour was removed. This had the pathological features of struma ovarii and autoradiographic evidence of pre-operatively administered 125I was seen in the lesion. The patient had positive results for long acting thyroid stimulator (LATS) and LATS-protector (LATS-P) pre- and post-operatively. Bioassays for thyroid stimulators were positive post-operatively but radioreceptor assays for TsAb were consistently negative. It is suggested that profile scanning is an appropriate investigation for diagnosis. It is not clear whether the lesion was autonomous or being stimulated by circulating thyroid stimulators.

Entities:  

Mesh:

Year:  1987        PMID: 3455373     DOI: 10.1111/j.1365-2265.1987.tb02955.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  3 in total

1.  Ectopic thyroid follicles in the submucosa of the duodenum.

Authors:  T Takahashi; H Ishikura; H Kato; T Tanabe; T Yoshiki
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 2.  Case Report: Recurrent Malignant Struma Ovarii With Hyperthyroidism and Metastases, A Rare Case Report and Review of the Literature.

Authors:  Ruyi Zhang; Xin Tian; Ying Luo; Haiwei Dong; Weijun Tian; Yujie Zhang; Dong Li; Haoran Sun; Zhaowei Meng
Journal:  Pathol Oncol Res       Date:  2022-05-10       Impact factor: 2.874

3.  Coexistence of Graves' disease and unilateral functioning Struma ovarii: a case report.

Authors:  Tullaya Sitasuwan; Suchanan Hanamornroongruang; Thavatchai Peerapatdit; Nuntakorn Thongtang
Journal:  BMC Endocr Disord       Date:  2015-11-04       Impact factor: 2.763

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.